Status:
COMPLETED
Cell Tracking Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI) - A Pilot Study
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
Royal College of Surgeons of Edinburgh
Translational Medicine Research Collaboration
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The ability to label specific cells and image their natural movements in vivo would allow researchers to investigate the mechanisms of disease progression. In addition, cell-based therapy, especially ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Age \>18 years
Exclusion
- Pregnancy
- Contraindication to MRI scanning (detected by safety questionnaire) including severe claustrophobia
- Inability or refusal to give informed consent
- Renal or hepatic dysfunction
- HIV/hepatitis B/ hepatitis C/ HTLV/ syphilis
- Intercurrent illness
- Blood dyscrasias
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00972946
Start Date
September 1 2009
End Date
January 6 2012
Last Update
June 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh/Royal Infirmary of Edinburgh
Edinburgh, United Kingdom, EH16 4SA